Copyright 2008 Medical News Today Latest Acid Reflux/GERD News From Medical News Today. http://www.medicalnewstoday.com/sections/gerd/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Tue, 01 Jul 2008 01:00:00 PDT http://www.medicalnewstoday.com/articles/113363.php Eisai Corporation of North America, a wholly-owned subsidiary of Tokyo-based Eisai Co., Ltd., announced that the Food and Drug Administration (FDA) has approved ACIPHEX (rabeprazole sodium) 20 mg for the short-term (up to eight weeks) treatment of gastroesophageal reflux disease (GERD) in adolescents ages 12 and above. Included in the submission was a 12-week, multi-center, open-label, randomized, parallel-group study of 111 adolescent GERD patients. Wed, 18 Jun 2008 07:00:00 PDT http://www.medicalnewstoday.com/articles/111802.php A nuclear medicine imaging test was used to confirm that children with respiratory problems may be more likely to develop gastroesophageal reflux disease, according to researchers at SNM's 55th Annual Meeting. The nuclear imaging technique, known as scintigraphy, was also shown to be more effective in detecting the disease in these children than traditional barium X-ray technology. Fri, 13 Jun 2008 04:00:00 PDT http://www.medicalnewstoday.com/articles/111120.php Mercy Medical Center has become the first hospital in the Northeast to offer a new, revolutionary non-invasive procedure that surgically treats chronic heartburn resulting from GastroEsophageal Reflux Disease (GERD). Thu, 05 Jun 2008 04:00:00 PDT http://www.medicalnewstoday.com/articles/110010.php The Restech Corporation announced that the Central California Ear, Nose & Throat Medical Group (CCENT) of Fresno, California, has adopted the Restech Dx-pH Measurement System to detect acid reflux in the throat. An alarming increase in the incidence of gastroesophageal reflux disease (GERD) and laryngopharyngeal reflux disease (LPRD) in Americans has led to the need for accurate diagnosis of acid reflux as provided by this system. Thu, 29 May 2008 04:00:00 PDT http://www.medicalnewstoday.com/articles/109121.php Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company, announced that it is developing a new tablet formulation to add to its ZEGERID® family of branded prescription pharmaceutical products. The new formulation is a swallowable tablet that combines immediate-release omeprazole, a proton pump inhibitor (PPI), with a mix of buffers. Santarus plans to undertake clinical and stability studies with the tablet in preparation for the submission of a New Drug Application to the U.S. Wed, 21 May 2008 04:00:00 PDT http://www.medicalnewstoday.com/articles/108244.php Gastroesophageal reflux disease (GERD) is described as the chronic symptoms and/or tissue damage caused by the reflux of abnormal gastric contents to the esophagus. GERD is a common disease, with associated typical symptoms of heartburn and regurgitation. An article published in the World Journal of Gastroenterology evaluated the clinical and endoscopic features in Chinese patients with reflux esophagitis. This study was conducted by Dr. Wed, 21 May 2008 02:00:00 PDT http://www.medicalnewstoday.com/articles/108150.php TAP Pharmaceutical Products Inc. have reported results from three pivotal Phase 3 studies evaluating investigational new drug TAK-390MR, the first proton pump inhibitor (PPI) with an innovative dual delayed release technology, in healing patients with erosive esophagitis (EE) and in maintenance of healed EE. The data were presented at the Digestive Disease Week (DDW) annual meeting in San Diego. Wed, 21 May 2008 01:00:00 PDT http://www.medicalnewstoday.com/articles/108092.php Despite the growing availability of prescription and over-the-counter medications for gastroesophageal reflux disease (GERD), surgical treatment remains a viable alternative for patients whose symptoms persist. In the May 2008 Archives of Surgery, surgeons from Massachusetts General Hospital (MGH) report their survey of almost 200 patients who had laparoscopic antireflux surgery at the MGH over a 10-year period. Tue, 20 May 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/107999.php A new, noninvasive gastroplasty device to treat two separate disorders gastroesophageal-reflux disease (GERD) and morbid obesity was reported by its inventor, Charles J. Filipi, M.D., professor of surgery at Creighton University School of Medicine. Filipi spoke about the device, which could be available for human trials later this year, on Monday, May 19, at the 49th annual Digestive Disease Week in San Diego, Calif. Sat, 17 May 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/107783.php Despite daily use of doctor-recommended proton pump inhibitors (PPIs) to control gastroesophageal reflux disease (GERD) symptoms, nearly 40 percent of patients who take them continue to experience breakthrough, which is a return of GERD symptoms, such as acid regurgitation and heartburn. Fri, 28 Mar 2008 06:00:00 PDT http://www.medicalnewstoday.com/articles/102071.php New clinical data from a phase II study confirms the competitive profile of Orexo's product OX17 in GERD patients, i.e. fast, effective and sustained inhibition of gastric acid production, a prerequisite for effective symptom relief in the patient. The result demonstrates the clinical potential of OX17 and is an important step in the development of a competitive product. GERD, gastroesofageal reflux disease, is a common ailment in the Western world. Fri, 28 Mar 2008 02:00:00 PDT http://www.medicalnewstoday.com/articles/101949.php Johns Hopkins Health Alerts has just published a review of the new GERD guidelines, for safe, effective treatment of your acid reflux. Treating GERD Effectively There are four types of treatments for gastroesophageal reflux disease (GERD): lifestyle measures, medication, surgery, and endoscopic procedures. Why it is important to treat GERD Treating GERD is important. Fri, 29 Feb 2008 01:00:00 PDT http://www.medicalnewstoday.com/articles/98928.php The U.S. Food and Drug Administration approved Nexium (esomeprazole magnesium) for short-term use in children ages 1-11 years for the treatment of gastroesophageal reflux disease (GERD). The agency approved Nexium in two forms, a delayed-release capsule and liquid form. Nexium is approved in 10 milligrams (mg) or 20 mg daily for children 1-11 years old compared to 20 mg or 40 mg recommended for pediatric patients 12 to 17 years of age. Wed, 27 Feb 2008 02:00:00 PDT http://www.medicalnewstoday.com/articles/98696.php EndoGastric Solutions, the world leader in natural orifice surgery products and procedures, announces outstanding results at the completion of 1-year follow-up on GERD patients in the phase 2 multi-center study of the first generation transoral incisionless fundoplication (TIF 1) procedure and first-generation EsophyX device. Fri, 15 Feb 2008 02:00:00 PDT http://www.medicalnewstoday.com/articles/97395.php It usually starts as reflux, but for 700 thousand Americans, it turns into something called Barrett's Esophagus.* Now the black raspberry may be one of the weapons Barrett's Esophagus patients have to stay strong and prevent the condition from turning into a deadly cancer. For more than 10 years, Danny Harris has struggled with heartburn after he eats. He learned his reflux has turned into something more serious - a condition called Barrett's Esophagus. Mon, 28 Jan 2008 02:00:00 PDT http://www.medicalnewstoday.com/articles/95262.php A recent study from the Agency for Healthcare Research and Quality shows that hospitalizations for disorders caused by gastroesophageal reflux disease or GERD rose 103 percent between 1998 and 2005. Also, hospitalizations for patients who had milder forms of GERD (in addition to the condition for which they were admitted), rose by 216 percent during the same time period. The numbers underscore the importance of seeing a physician if symptoms suggestive of GERD are present. Fri, 11 Jan 2008 02:00:00 PDT http://www.medicalnewstoday.com/articles/93704.php A simple scale (None, Mild, Moderate, Severe) is frequently used to grade heartburn severity in clinical trials as well as in clinical practice and the question is whether this scale captures the heartburn severity well enough. Fri, 11 Jan 2008 02:00:00 PDT http://www.medicalnewstoday.com/articles/93686.php If you're constantly reaching for antacids to control your heartburn, you may have a more serious problem called reflux disease. Some 25 million Americans have it* and now they have a new option to treat it. Using a newly-approved device for the first time in the U.S., doctors have performed surgery to fix reflux problems without making a single incision. Developing the technology took decades, but the operation only took an hour. Mon, 07 Jan 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/93124.php Hospitalizations for treating disorders caused by gastroespohageal reflux disease (GERD ) increased by 103 percent between 1998 and 2005, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. During the same period, hospitalizations of patients who, in addition to the ailment for which they were admitted, had milder forms of GERD, rose by 216 percent. Fri, 04 Jan 2008 02:00:00 PDT http://www.medicalnewstoday.com/articles/93034.php If you're constantly reaching for antacids to control your heartburn, you may have a more serious problem called reflux disease. Some 25 million Americans have it* and now they have a new option to treat it. Using a newly-approved device for the first time in the U.S., doctors have performed surgery to fix reflux problems without making a single incision. Developing the technology took decades, but the operation only took an hour. Fri, 04 Jan 2008 02:00:00 PDT http://www.medicalnewstoday.com/articles/93029.php Gastroesophageal reflux disease (GERD), often known as acid reflux, is a common problem that has been associated with cancers, asthma, recurrent aspiration and pulmonary fibrosis. A new study published in The American Journal of Gastroenterology examines whether GERD sufferers may have shorter lifespans than those without the disease. Fri, 04 Jan 2008 02:00:00 PDT http://www.medicalnewstoday.com/articles/93027.php The number of people hospitalized because of GERD (gastroesophageal reflux disease) in the USA rose 103% between the period 1998 and 2005, according to details published by the Agency for Healthcare Research and Quality (AHRC). During that same period there was a 216% rise in the number of patients hospitalized for other ailments but who also had milder forms of GERD. A person who suffers GERD experiences chronic heartburn because stomach acid backs up into the esophagus. Fri, 04 Jan 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/92872.php It is estimated that the National Health Service (NHS) spends at least £100m per year on needless indigestion drugs, according to an editorial published in the British Medical Journal (BMJ). The UK is not alone in this kind of spending - apparently, almost £2bn are spent globally on such drugs each year. Two gastroenterology doctors at King's College Hospital, London, write that proton pump inhibitors are the most commonly prescribed classes of drug worldwide. Mon, 24 Dec 2007 01:00:00 PDT http://www.medicalnewstoday.com/articles/92674.php The American Society for Gastrointestinal Endoscopy (ASGE) has issued guidelines for the role of endoscopy in treating dyspepsia, discomfort thought to arise from the upper-gastrointestinal tract, which affects a fourth of the population in Western countries. An upper endoscopy is a procedure which uses an instrument to evaluate the inside of the esophagus, stomach and small intestine. Fri, 30 Nov 2007 02:00:00 PDT http://www.medicalnewstoday.com/articles/90290.php AstraZeneca announced that it has received Swedish Medical Products Agency (MPA) approval for use of Nexium(R) (esomeprazole) in children aged 1-11 years with gastroesophageal reflux disease (GERD) in the reference member state of Sweden, with other European Union nations expected to follow.1 Nexium® will become the first of the proton pump inhibitors (PPI) currently available for the treatment of pediatric GERD to have a specific formulation developed for children.